In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Non-Muscle Invasive Bladder Carcinoma · Stage 0a Bladder Cancer AJCC v8 · Stage I Bladder Cancer AJCC v8 · Stage 0is Bladder Cancer AJCC v8

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mayo Clinic in Florida, Jacksonville, Florida, United States
Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015
Contact: Principal Investigator (Timothy D. Lyon, MD)

Study leads

Timothy D. Lyon, MD
Principal Investigator
Mayo Clinic

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer

Recurrent Non-Muscle Invasive Bladder Carcinoma · Stage 0a Bladder Cancer AJCC v8 · Stage 0is Bladder Cancer AJCC v8

Abroad (travel likely)RecruitingPHASE1

Sacramento, United States

The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy

Bladder Cancer

Abroad (travel likely)RecruitingPHASE2

Goyang-si, South Korea

Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer

Bladder Cancer · Liquid Biopsy · Immunotherapy

Abroad (travel likely)RecruitingPHASE2

Tianjin, China · Tianjin, China

A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)

Bladder Cancer · Urinary Bladder Neoplasms

IsraelRecruitingPHASE1, PHASE2

Bakersfield, United States · Myrtle Beach, United States